Search
for
Sort by
Research 901–930 of 1000+
- Autoimmune Polyglandular Syndrome Type 1 in Russian Patients: Clinical Variants and Autoimmune Regulator Mutations
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Cardiovascular risk factors in young Czech females with polycystic ovary syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- Mood disorders and quality of life in polycystic ovary syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME